Optimizing microbial culture for better biosimilars. #BiosimilarsLatAm - #Global2026, Mario Novoa (INFORS HT, Mexico) will present innovative solutions for scalable, reliable #bioprocessing. 📅 Feb 24–25 | Online 🔗 Register now: lnkd.in/edSah_rn #Biosimilars

Last Chance to Register! jackleckerman.com/events/registe… #BiosimilarsLatAm – #Global2026, Connecting Latin America’s Opportunities with the World February 24–25 | Online | Global Audience

We’re live at #BiosimilarsLatAm - #Global2026. Christian Garnica, COFEPRIS shared how accelerated reviews & recognition of robust comparability data are increasing biosimilar access in Mexico. 3 live blocks still ahead. Join the discussion. Ask questions. Share insights.

LIVE at #BiosimilarsLatAm - #Global2026: How many companies can lead biosimilar production given high costs? Srinivas Komala (MSN Labs): #Biosimilars aren’t small molecules — fewer players, high investment. Regulatory reliance & reduced bridging studies could lower barriers.

LIVE at #BiosimilarsLatAm: Thomas Kirchlechner (Sandoz/IGBA): The glue of biosimilar development = physicochemical + functional + PK data. Future approvals will hinge more on analytics than large clinical trials. 3 session blocks to go. Join the dialogue. #Biosimilars

LIVE at #BiosimilarsLatAm: Vanessa Schiavo (Bionovis S.A.) on PDP challenges: • Tech transfer timelines • Managing evolving manufacturing methods • Cost pressures • Public bottlenecks Goal: National autonomy in biologics production. Final block still ahead today. #Biosimilars

LIVE at #BiosimilarsLatAm: Rodrigo Ruíz Ramírez 🇲🇽: Sustainable success in LATAM isn’t just about profit benchmarks — it’s about balancing innovation with regulatory compliance. Transparency + digital evidence + early engagement = key. Final block remain. Join us! #Biosimilars

LIVE at #BiosimilarsLatAm: Mario Novoa (INFORS HT): Backscatter monitoring works for biomass in microbial cultures — but not all injectable products generate usable signals. Right tech for the right biology. Final session block still ahead today. #Bioprocessing #Biosimilars

LIVE at #BiosimilarsLatAm: Devendra Ridhurkar (RidNova Pharmaceuticals 🇪🇸) on nanotechnology & injectable #biosimilars: Lipid nanoparticles, exosomes & cell-based therapies are advancing targeted delivery, stability & personalized medicine. Final session block ahead. Join us.

Thank you for making #BiosimilarsLatAm - #Global2026 a success. Grateful to our speakers, partners and to our global participants — your engagement made the difference. The dialogue continues. jackleckerman.com #Biosimilars #Biopharma #GlobalHealth

At #BiosimilarsLatAm: Uri Mendoza (Promovus Consulting 🇲🇽): Start with Quality by Design & EMA/FDA compliance from day one. Early global alignment reduces risk, eases scale-up & enables smoother market entry. Conversations continues jackleckerman.com #Biosimilars #Biotech

#BiosimilarsLatAm – #Global2026 Relive the highlights of our global forum bringing together regulators, industry leaders, and experts to discuss the future of biosimilars. Connecting Latin America’s opportunities with the world. jackleckerman.com #Biosimilars #Biotech